(4 years, 2 months ago)
Lords ChamberMy Lords, the funding I spoke of in my original Answer will contribute to the supply of 1 billion doses in 2021 and the vaccination of up to 500 million people. We believe that the right way forward is for the world to come together through the COVAX commitment. On the specific proposal that the noble Lord mentioned, I will have to look at that in detail and come back to him in writing.
My Lords, it is reported that the UK has bought six experimental vaccines, stockpiling 340 million doses, awaiting the results of clinical trials. While this is probably a wise strategy, can the Minister say how much the Government have paid for these? This is enough to vaccinate our population five times over; will any surplus licensed stock be distributed to poorer countries?
My Lords, our commitment to global access to Covid-19 medical tools includes supporting voluntary methods of sharing intellectual property and non-exclusive voluntary licensing agreements. We think it is right to follow both bilateral deals and the COVAX joint facility to maximise the chances of finding a vaccine.
(4 years, 7 months ago)
Lords ChamberMy Lords, Gavi itself will help fund equitable access to and the distribution of vaccines. That is why it is so important that the world comes together to ensure that it gets the funding it needs.
My Lords, health systems in the countries where Gavi operates programmes are very stretched, and routine vaccination programmes are suffering from movement restrictions. What assessment have the Government made of the risk of a re-emergence of the diseases which have been suppressed or even eliminated through Gavi’s work?
My Lords, we are concerned about a resurgence. In addition to helping health systems respond to Covid-19, Gavi is helping poor countries adapt immunisation programmes. In areas where childhood immunisation services are disrupted, Gavi is planning an immunisation catch-up campaign to reach unimmunised children.